Wolverine Asset Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Buy
179,984
+119,668
+198% +$903K 0.01% 858
2026
Q2
$628K Sell
60,316
-8,664
-13% -$96.7K 0.01% 902
2026
Q1
$821K Hold
68,980
– – 0.01% 821
2025
Q4
$687K Hold
68,980
– – 0.01% 866
2025
Q3
$617K Hold
68,980
– – ﹤0.01% 829
2025
Q2
$650K Hold
68,980
– – 0.01% 817
2025
Q1
$748K Hold
68,980
– – 0.01% 765
2024
Q4
$657K Hold
68,980
– – 0.01% 804
2024
Q3
$775K Hold
68,980
– – 0.01% 764
2024
Q2
$690K Hold
68,980
– – 0.01% 771
2024
Q1
$794K Buy
+68,980
New +$586K 0.01% 713
2021
Q3
– Sell
-96
Closed -$2K – 1971
2021
Q2
$2K Buy
+96
New +$2.74K ﹤0.01% 2092
2019
Q4
– Sell
-636,848
Closed -$6.48M – 1342
2019
Q3
$6.48M Buy
636,848
+536,848
+537% +$5.48M 0.08% 190
2019
Q2
$1.01M Buy
+100,000
New +$1.01M 0.01% 642

Other funds holding AHCO

Wolverine Asset Management's AHCO Position: Q3 2026 in Review

Wolverine Asset Management increased its AdaptHealth (AHCO) stake by 198% in Q3 2026, buying an estimated $903K and bringing the position to 179,984 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #858.

Wolverine Asset Management first reported a position in AHCO in Q2 2019 and has held it in 14 quarters since. The position peaked at $6.48M in Q3 2019. 248 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Wolverine Asset Management held 179,984 shares of AdaptHealth worth $1.02M as of Q3 2026.
  • Wolverine Asset Management bought 119,668 AdaptHealth shares in Q3 2026, an estimated $903K.
  • AdaptHealth made up 0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #858 holding.
  • Wolverine Asset Management first reported a position in AdaptHealth in Q2 2019 and has held it in 14 quarters since.
  • Wolverine Asset Management's AdaptHealth position peaked at $6.48M in Q3 2019.
  • 248 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.